← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 1, 2021Last known activity
Dec 30, 2025
Timeline
2010s
- Jun 1, 2014
InSilico Medicine Hong Kong Limited— Founded
Drugs by trial phase (10 distinct, 10 trials)
Phase 2 (2 own, 0 via acquisition)
Recent trials (10)
- NCT06724042Lead sponsorPhase 1Dec 30, 2025
- NCT07265570Lead sponsorPhase 2Dec 10, 2025
- NCT06414460Lead sponsorPhase 1Mar 1, 2025
- NCT06566079Lead sponsorPhase 1Oct 30, 2024
- NCT06445517Lead sponsorPhase 1Apr 25, 2024
- NCT05975983Lead sponsorPhase 2Dec 15, 2023
- NCT06012578Lead sponsorPhase 1Nov 8, 2023
- NCT05932862Lead sponsorPhase 1Aug 17, 2023
- NCT05938920Lead sponsorPhase 2Jun 19, 2023
- NCT05154240Lead sponsorPhase 1Dec 1, 2021
Details
- Founded
- Hong Kong, HK Jun 1, 2014
- Last known activity
- Dec 30, 2025